Tachosil Purple Book BLA 125351

BLA number
125351
Proprietary names
Tachosil
Proper names
Fibrin Sealant Patch
Applicant
Corza Medical GmbH
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001TachosilFibrin Sealant Patch351(a)4.8 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBINPatchTopicalTray & LidRxLicensed2010-04-05
002TachosilFibrin Sealant Patch351(a)9.5 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBINPatchTopicalTray & LidRxLicensed2010-04-05
003TachosilFibrin Sealant Patch351(a)3.0 CM X 2.5 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBINPatchTopicalTray & LidDiscLicensed2010-04-05

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2022-04-01U001Tachosil351(a)RxCorza Medical GmbH
2022-04-01U002Tachosil351(a)RxCorza Medical GmbH
2022-04-01U003Tachosil351(a)DiscCorza Medical GmbH
2021-05-01U001Tachosil351(a)RxTakeda Pharma A/S
2021-05-01U002Tachosil351(a)RxTakeda Pharma A/S
2021-05-01U003Tachosil351(a)DiscTakeda Pharma A/S
2020-08-01R001Tachosil351(a)RxTakeda Pharma A/S
2020-08-01R002Tachosil351(a)RxTakeda Pharma A/S
2020-08-01R003Tachosil351(a)DiscTakeda Pharma A/S

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-08-01001Tachosil351(a)RxLicensed2010-04-05
2020-08-01002Tachosil351(a)RxLicensed2010-04-05
2020-08-01003Tachosil351(a)DiscLicensed2010-04-05